Herpes Simplex Infections
|
0.020 |
Biomarker
|
group |
LHGDN |
Functional interaction between class II histone deacetylases and ICP0 of herpes simplex virus type 1.
|
15194749 |
2004 |
Mental Depression
|
0.500 |
Biomarker
|
disease |
PSYGENET |
Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior.
|
16501568 |
2006 |
Depressive disorder
|
0.300 |
Biomarker
|
disease |
PSYGENET |
Furthermore, viral-mediated HDAC5 overexpression in the hippocampus blocked imipramine's ability to reverse depression-like behavior.
|
16501568 |
2006 |
Major Depressive Disorder
|
0.320 |
Biomarker
|
disease |
PSYGENET |
Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
|
17258370 |
2007 |
Major Depressive Disorder
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
|
17258370 |
2007 |
Unipolar Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
|
17258370 |
2007 |
Unipolar Depression
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
Our results suggest the alteration of HDAC5 and CREB gene expression in the systemic pathophysiology of major depression.
|
17258370 |
2007 |
Cocaine Dependence
|
0.310 |
Therapeutic
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Adjustment Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Cocaine Abuse
|
0.300 |
Therapeutic
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Reactive depression
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Cocaine-Related Disorders
|
0.300 |
Therapeutic
|
group |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Transient Situational Disturbance
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli.
|
17988634 |
2007 |
Heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
Moreover, adenovirus-mediated overexpression of PKD, CaMKIIdelta(B), or CaMKIIdelta(C) reduced baseline HDAC5 F(nuc)/F(cyto) in control myocytes (3.4+/-0.5, 3.8+/-0.5, and 5.2+/-0.5, respectively), approaching that seen in HF.
|
18218981 |
2008 |
Congestive heart failure
|
0.020 |
Biomarker
|
disease |
BEFREE |
Moreover, adenovirus-mediated overexpression of PKD, CaMKIIdelta(B), or CaMKIIdelta(C) reduced baseline HDAC5 F(nuc)/F(cyto) in control myocytes (3.4+/-0.5, 3.8+/-0.5, and 5.2+/-0.5, respectively), approaching that seen in HF.
|
18218981 |
2008 |
Attention Deficit Disorder
|
0.200 |
Biomarker
|
disease |
RGD |
A comparison of molecular alterations in environmental and genetic rat models of ADHD: a pilot study.
|
18937310 |
2008 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies.
|
19801982 |
2009 |
Bone Density
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies.
|
19801982 |
2009 |
Primary osteoporosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans.
|
19920351 |
2009 |
Arteriosclerosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, our results reveal that phosphorylation-dependent derepression of HDAC5 mediates flow-induced KLF2 and eNOS expression as well as flow anti-inflammation, and suggest that HDAC5 could be a potential therapeutic target for the prevention of atherosclerosis.
|
20042720 |
2010 |
Atherosclerosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Taken together, our results reveal that phosphorylation-dependent derepression of HDAC5 mediates flow-induced KLF2 and eNOS expression as well as flow anti-inflammation, and suggest that HDAC5 could be a potential therapeutic target for the prevention of atherosclerosis.
|
20042720 |
2010 |
Renal cyst
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Polycystin-dependent fluid flow sensing targets histone deacetylase 5 to prevent the development of renal cysts.
|
20181743 |
2010 |
Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, we conducted functional studies using siRNA-mediated knockdown of HDAC5 and HDAC9 in medulloblastoma cells.
|
20413433 |
2010 |
Childhood Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, we conducted functional studies using siRNA-mediated knockdown of HDAC5 and HDAC9 in medulloblastoma cells.
|
20413433 |
2010 |
Adult Medulloblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In addition, we conducted functional studies using siRNA-mediated knockdown of HDAC5 and HDAC9 in medulloblastoma cells.
|
20413433 |
2010 |